Skip to main content

agilon health, inc.

AGL
Exchange
NYSE
Industry
Services-Misc Health & Allied Services, NEC
SEC CIK
0001831097

No open-market purchases or sales by agilon health, inc. insiders were filed in the last 90 days; 179 institutions reported holding it in 13F filings for Q2 2026, worth $1.73B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by agilon health, inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for agilon health, inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for agilon health, inc.
NameTitleLast reported holdingLast filingFilings, past year
Gertsch TimothyChief Accounting Officer14,152Aug 18, 20264
Zamore DeniseChief Legal Officer66,075Aug 4, 20265
Schwaneke Jeffrey A.Chief Financial Officer138,031Jul 2, 20263
Williams Ronald ADirector149,141Jun 4, 20261
Mansukani SharadDirector56,242Jun 4, 20261
McLoughlin KarenDirector8,207Jun 4, 20261
McKenzie DianaDirector7,633Jun 4, 20261
Battaglia SilvanaDirector7,926Jun 4, 20261
Wulf John WilliamDirector16,765Jun 4, 20262
O'Rourke Timothy PatrickCEO & President320,000May 11, 20261
Venkatachaliah GirishChief Technology Officer38,236Apr 16, 20263
Shaker BenjaminChief Markets Officer122,850Apr 16, 20264
Sell StevenCEO & President862,122Apr 16, 20250
Bensley TimothyChief Financial Officer39,387Apr 17, 20240
Desai VeeralChief Strategy & Dev. Officer498,013Apr 17, 20240
Kornitzer BenjaminChief Med. & Quality Officer62,058Mar 18, 20240
CD&R Investment Associates IX, Ltd.10% Owner100,000,000IndirectMay 18, 20230
CD&R Vector Holdings, L.P.10% Owner100,000,000IndirectMay 18, 20230
Kasenchak PriscillaChief Accounting Officer7,745Apr 18, 20230
Richards ClayDirector41,214Apr 18, 20230
Sobotka GlennChief Accounting Officer5,365Sep 29, 20220
Smith Michael LDirector4,126IndirectMay 27, 20220
Gourdine Michelle ADirector18,892Apr 20, 20220
Halkias TheodoreChief Business Officer5,434Jan 3, 20220
Danieley JoanChief Administrative Officer5,434Dec 21, 20210
Dombro LisaExper. & Innovation Officer11,956Sep 15, 20210
Schnall Richard JDirector0Sep 13, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 11, 2026 (view filing)Mar 92 daysZamore DeniseChief Legal OfficerPPurchase+5.54K––+1.2%448.7K after
Mar 11, 2026 (view filing)Mar 92 daysVenkatachaliah GirishChief Technology OfficerPPurchase+18.4K––+6.9%285.1K after
Mar 11, 2026 (view filing)Mar 92 daysShaker BenjaminChief Markets OfficerPPurchase+18.4K––+1.3%1.39M after
Mar 3, 2026 (view filing)Mar 21 dayShaker BenjaminChief Markets OfficerPPurchase+500.0K$0.60+$300.0K+57.6%1.37M after
Jan 30, 2026 (view filing)Nov 12, 202579 daysLateWulf John WilliamDirectorPPurchase+81.0K$0.63+$51.0K+28.4%365.9K after
Apr 3, 2025 (view filing)Nov 29, 2023491 daysSchwaneke Jeffrey A.Chief Financial OfficerPPurchase+22.3K$11.22+$250.2KNew position22.3K afterAmended
Mar 18, 2025 (view filing)Mar 144 daysSell StevenCEO & PresidentPPurchase+42.4K––+12.9%370.9K after
Mar 18, 2025 (view filing)Mar 144 daysShaker BenjaminChief Markets OfficerPPurchase+11.8K––+2.6%461.2K after
Mar 18, 2025 (view filing)Mar 144 daysVenkatachaliah GirishChief Technology OfficerPPurchase+9.43K––+6.3%158.4K after
Dec 13, 2024 (view filing)Dec 13Same dayMcLoughlin KarenDirectorPPurchase+25.0K$2.20+$55.0K+51.9%73.2K after
Dec 13, 2024 (view filing)Dec 112 daysBattaglia SilvanaDirectorPPurchase+25.1K$2.01+$50.4K+61.0%66.1K after
Dec 11, 2024 (view filing)Nov 25-Dec 916 daysLateMcKenzie DianaDirectorPPurchase+20.0K$2.25+$45.0K+51.5%58.8K after2 lots
Dec 11, 2024 (view filing)Dec 56 daysLateWulf John WilliamDirectorPPurchase+45.0K$2.18+$98.1K+27.9%206.1K after
Sep 16, 2024 (view filing)Sep 124 daysSell StevenCEO & PresidentPPurchase+20.0K$3.36+$67.2K+42.0%67.6K after
Mar 18, 2024 (view filing)Mar 144 daysKornitzer BenjaminChief Med. & Quality OfficerPPurchase+5.43K––+9.3%63.9K after
Mar 18, 2024 (view filing)Mar 144 daysVenkatachaliah GirishChief Technology OfficerPPurchase+5.43K––+14.9%41.8K after
Mar 18, 2024 (view filing)Mar 144 daysShaker BenjaminChief Markets OfficerPPurchase+274.5K––+345.0%354.0K after
Mar 18, 2024 (view filing)Mar 144 daysDesai VeeralChief Strategy & Dev. OfficerPPurchase+12.0K––+4.0%311.5K after
Mar 18, 2024 (view filing)Mar 144 daysBensley TimothyChief Financial OfficerPPurchase+14.9K––+42.5%50.1K after
Nov 21, 2023 (view filing)Nov 21Same daySell StevenCEO & PresidentPPurchase+44.7K$11.14+$497.8K+1,541.0%47.6K after
Sep 14, 2023 (view filing)Sep 12-132 daysShaker BenjaminChief Markets OfficerSSale−37.5K$18.03−$675.9K−32.0%79.5K after2 lots10b5-1
Sep 13, 2023 (view filing)Sep 112 daysGertsch TimothyChief Accounting OfficerSSale−26.3K$18.62−$488.7K−60.5%17.1K after2 lots
Aug 16, 2023 (view filing)Aug 14-152 daysShaker BenjaminChief Markets OfficerSSale−37.5K$18.41−$690.4K−32.0%79.5K after2 lots10b5-1
Jul 14, 2023 (view filing)Jul 12-132 daysShaker BenjaminChief Markets OfficerSSale−37.5K$16.95−$635.6K−32.0%79.5K after2 lots10b5-1
Jun 16, 2023 (view filing)Jun 14-152 daysShaker BenjaminChief Markets OfficerSSale−37.5K$18.65−$699.3K−32.0%79.5K after4 lots
May 18, 2023 (view filing)4:05 PM ETMay 18Same dayCD&R Investment Associates IX, Ltd. and 1 other10% OwnerSSale−94.2M$20.80−$1.96B−48.5%100.0M after
May 17, 2023 (view filing)May 15-162 daysShaker BenjaminChief Markets OfficerSSale−50.0K$23.47−$1.17M−38.6%79.5K after2 lots10b5-1
May 11, 2023 (view filing)May 92 daysDesai VeeralChief Strategy & Dev. OfficerSSale−4.50K$26.15−$117.7K−1.5%299.6K after10b5-1
Apr 21, 2023 (view filing)Apr 19-202 daysDesai VeeralChief Strategy & Dev. OfficerSSale−5.50K$26.84−$147.6K−1.8%299.6K after3 lots10b5-1
Apr 19, 2023 (view filing)Apr 17-182 daysShaker BenjaminChief Markets OfficerSSale−50.0K$27.90−$1.39M−38.6%79.5K after3 lots10b5-1
Mar 27, 2023 (view filing)Mar 23-244 daysDesai VeeralChief Strategy & Dev. OfficerSSale−120.0K$28.70−$3.44M−30.2%276.7K after2 lots
Mar 24, 2023 (view filing)Mar 22-232 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−16.2K$27.94−$452.3K−22.6%55.4K after2 lots
Mar 17, 2023 (view filing)Mar 152 daysWulf John WilliamDirectorSSale−80.0K$23.82−$1.91M−39.3%123.4K after
Mar 17, 2023 (view filing)Mar 15-162 daysShaker BenjaminChief Markets OfficerSSale−85.0K$24.33−$2.07M−58.4%60.6K after5 lots
Mar 17, 2023 (view filing)Mar 152 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−55.0K$23.81−$1.31M−49.8%55.4K after
Mar 17, 2023 (view filing)Mar 161 dayDesai VeeralChief Strategy & Dev. OfficerSSale−60.0K$26.09−$1.57M−17.8%276.7K after
Mar 9, 2023 (view filing)Mar 7-82 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−16.2K$24.40−$395.0K−60.8%10.4K after2 lots
Feb 16, 2023 (view filing)Feb 14-152 daysShaker BenjaminChief Markets OfficerSSale−78.6K$23.12−$1.82M−75.4%25.6K after2 lots
Feb 16, 2023 (view filing)Feb 14-152 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−34.0K$22.99−$781.0K−76.5%10.4K after2 lots
Feb 3, 2023 (view filing)Feb 1-22 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−36.2K$22.81−$825.1K−77.6%10.4K after2 lots
Jan 23, 2023 (view filing)Jan 19-204 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−16.2K$19.79−$320.4K−60.8%10.4K after2 lots
Jan 19, 2023 (view filing)Jan 17-182 daysShaker BenjaminChief Markets OfficerSSale−46.4K$19.85−$922.0K−64.4%25.6K after2 lots
Jan 9, 2023 (view filing)Jan 5-64 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−5.40K$15.49−$83.6K−34.1%10.4K after2 lots
Dec 16, 2022 (view filing)Dec 14-152 daysShaker BenjaminChief Markets OfficerSSale−37.5K$17.39−$652.1K−59.4%25.6K after2 lots
Dec 7, 2022 (view filing)Dec 5-62 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$17.76−$191.7K−50.9%10.4K after2 lots
Nov 22, 2022 (view filing)Nov 184 daysSell StevenCEO & PresidentPPurchase+2.90K$17.14+$49.7KNew position2.90K after
Nov 18, 2022 (view filing)Nov 16-172 daysShaker BenjaminChief Markets OfficerSSale−37.5K$17.73−$664.9K−59.4%25.6K after2 lots
Nov 18, 2022 (view filing)Nov 16-172 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$17.98−$194.0K−50.9%10.4K after2 lots
Nov 3, 2022 (view filing)Nov 1-22 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$19.78−$213.5K−50.9%10.4K after2 lots
Oct 21, 2022 (view filing)Oct 19-202 daysShaker BenjaminChief Markets OfficerSSale−50.0K$20.16−$1.01M−66.1%25.6K afterAmended4 lots